Acceleron Pharma Inc EV/Sales
Qual é o EV/Sales de Acceleron Pharma Inc?
O EV/Sales de Acceleron Pharma Inc é 91.88
Qual é a definição de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales de empresas na Setor Health Care em NASDAQ em comparação com Acceleron Pharma Inc
O que Acceleron Pharma Inc faz?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Empresas com ev/sales semelhantes a Acceleron Pharma Inc
- Eaton Vance Tax-Managed Global Diversified Equity Income Fund tem EV/Sales de 90.79
- genedrive plc tem EV/Sales de 90.81
- Royce Micro-Cap Trust Inc tem EV/Sales de 91.14
- Fairfax India tem EV/Sales de 91.22
- Honda Motor tem EV/Sales de 91.24
- Novonix tem EV/Sales de 91.58
- Acceleron Pharma Inc tem EV/Sales de 91.88
- China Huarong tem EV/Sales de 91.97
- Zeotech tem EV/Sales de 92.09
- Castillo Copper tem EV/Sales de 92.20
- Carnival International tem EV/Sales de 92.27
- Imagion Biosystems tem EV/Sales de 92.51
- Syntonic tem EV/Sales de 92.53